Novacap completes th
Novacap completes the acquisition of PCI Synthesis and expands its pharmaceutical offerings in the U.S.
28 juin 2018 12h01 HE | PCI Synthesis; Novacap
LYON, France and NEWBURYPORT, Mass., June 28, 2018 (GLOBE NEWSWIRE) -- Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has completed the...
Novacap to expand it
Novacap to expand its pharmaceutical offering in the U.S. with the acquisition of PCI Synthesis
20 juin 2018 12h03 HE | PCI Synthesis; Novacap
LYON, France and NEWBURYPORT, Mass., June 20, 2018 (GLOBE NEWSWIRE) -- Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has signed an...
PCI Synthesis Celebr
PCI Synthesis Celebrates Key Milestones Including 4th Consecutive Year of Double-Digit Growth, 2 Commercial Approvals and a New Office in San Diego
27 févr. 2018 09h15 HE | PCI Synthesis
NEWBURYPORT, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEis), generic active pharmaceutical...
PCI Synthesis Submit
PCI Synthesis Submits Patent for Synthesizing Azelaic Acid
30 janv. 2018 09h15 HE | PCI Synthesis
NEWBURYPORT, Mass., Jan. 30, 2018 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
PCI Synthesis Co-Sponsors Third Annual Massachusetts CRO/CMO Symposium
22 avr. 2014 09h17 HE | PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Apr 22, 2014) -  PCI Synthesis, a Boston-based Contract Manufacturing Organization (CMO) that manufacturers new chemical entities (NCEs), generic active...
PCI Synthesis to Pick Up Four 2013 CMO Leadership Awards
10 mars 2014 09h17 HE | PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Mar 10, 2014) - PCI Synthesis, Inc. (www.pcisynthesis.com), a Boston-based Contract Manufacturing Organization (CMO) that manufactures new chemical entities (NCE),...
PCI Synthesis Announces 2014 Trends and Predictions
09 déc. 2013 11h23 HE | PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Dec 9, 2013) - PCI Synthesis, Inc. (www.pcisynthesis.com), a 15-year-old pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
PCI Launches Innovative Product Line: Phosphonic Acids, Used in a Wide Variety of Commercial Applications
05 déc. 2013 09h46 HE | PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Dec 5, 2013) - PCI (www.pcisynthesis.com), a Boston-based Contract Manufacturing Organization (CMO) that manufacturers new chemical entities (NCEs), generic active...
PCI Synthesis Wins Four 2013 CMO Leadership Awards
04 nov. 2013 09h13 HE | PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Nov 4, 2013) - PCI Synthesis, Inc. (www.pcisynthesis.com), a Boston-based Contract Manufacturing Organization (CMO) that manufactures new chemical entities (NCE),...
Glenn Killingworth Joins PCI as VP of Business Development
07 oct. 2013 09h30 HE | PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Oct 7, 2013) - PCI Synthesis, Inc. (www.pcisynthesis.com), a custom chemical manufacturer of new chemical entities (NCE), generic active pharmaceutical ingredients...